How to avoid making buggy whips

How to avoid making buggy whips

July 26, 2016

Manufacturers’ Monthly's first Manufacturing Leaders of Innovation event was hosted on 21 July 2016 at Trajan's Global Corporate Headquarters in Melbourne, Australia, and supported by Autodesk.

From Manufacturers' Monthly:

Innovation might be a word some are sick of, but it remains essential for success. Melbourne-based manufacturer Trajan Scientific and Medical shared a few insights into what it involves for them.

Read the full article at Manufacturers' Monthly: How to avoid making buggy whips

Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical speaking at Manufacturing Leaders of Innovation event
Photo: Dr Andrew Gooley, Chief Scientific Officer, Trajan Scientific and Medical speaking at Manufacturing Leaders of Innovation event.




Also in News

Trajan acquires Axel Semrau, a laboratory automation, chromatography, and software business
Trajan acquires Axel Semrau, a laboratory automation, chromatography, and software business

November 24, 2021

Trajan Scientific and Medical has finalized the acquisition of the latest addition to their portfolio, Axel Semrau GmbH & Co expanding its capabilities in the automation, chromatography, and software business.

Read More

Trajan completes ISO 9001 recertification
Trajan completes ISO 9001 recertification

July 14, 2021

Trajan Scientific and Medical has successfully completed a 3-year ISO 9001:2015 recertification at our Ringwood global headquarters this week, cementing the importance that we place over quality management and continuous improvement for ourselves and all stakeholders.

Read More

Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth
Global analytical science and device company Trajan Group announces IPO and $50M capital injection to fuel next phase of growth

May 17, 2021

Global analytical science and device company Trajan Group Holdings Limited (Trajan or the Company) has launched a $90 million IPO to support the next phase of accelerated growth.

Read More